STOCKHOLDERS' DEFICIT, STOCK OPTIONS AND WARRANTS (Details Textual) (USD $)	0 Months Ended	1 Months Ended												2 Months Ended		3 Months Ended	6 Months Ended	12 Months Ended				140 Months Ended						1 Months Ended	2 Months Ended		6 Months Ended	12 Months Ended																0 Months Ended	3 Months Ended			1 Months Ended				12 Months Ended							2 Months Ended	12 Months Ended			12 Months Ended				2 Months Ended	12 Months Ended			12 Months Ended
	Mar. 15, 2013	Oct. 31, 2013	May 31, 2013	Apr. 30, 2013	Jan. 31, 2013	Nov. 30, 2012	Jan. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Oct. 31, 2009	Jul. 31, 2007	Mar. 31, 2007	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2013	Sep. 11, 2013	Jan. 15, 2013	Mar. 28, 2012	Sep. 07, 2011	Jun. 22, 2010	Jan. 31, 2013 Private Placement [Member]	Jun. 30, 2013 Private Placement [Member]	Jun. 30, 2013 Private Placement 2 [Member]	Jun. 30, 2013 Private Placement 2 [Member]	Dec. 31, 2013 Warrant [Member]		Dec. 31, 2012 Warrant [Member]		Dec. 31, 2011 Warrant [Member]		Dec. 31, 2010 Warrant [Member]		Dec. 31, 2009 Warrant [Member]		Dec. 31, 2008 Warrant [Member]		Dec. 31, 2007 Warrant [Member]		Dec. 31, 2006 Warrant [Member]		Mar. 15, 2013 Warrant [Member] Private Placement [Member]	Mar. 31, 2013 Warrant [Member] Private Placement [Member]	Sep. 10, 2013 Stock Incentive Plan 2012 [Member]	Apr. 15, 2013 Stock Incentive Plan 2012 [Member]	Nov. 30, 2012 Convertible Notes One [Member]	Nov. 30, 2012 Convertible Notes Two [Member]	Nov. 30, 2012 Convertible Notes Three [Member]	Nov. 30, 2012 Convertible Note Four [Member]	Dec. 31, 2013 Stock Options and Warrants [Member]	Dec. 31, 2012 Stock Options and Warrants [Member]	Dec. 31, 2011 Stock Options and Warrants [Member]	Dec. 31, 2013 Stock Options and Warrants One [Member]	Dec. 31, 2012 Stock Options and Warrants One [Member]	Dec. 31, 2013 Stock Options and Warrants Two [Member]	Dec. 31, 2012 Stock Options and Warrants Two [Member]	Sep. 30, 2013 Minimum [Member]	Dec. 31, 2013 Minimum [Member]	Dec. 31, 2008 Minimum [Member]	Sep. 10, 2013 Minimum [Member]	Dec. 31, 2013 Minimum [Member] Warrant [Member]	Dec. 31, 2013 Minimum [Member] Stock Options and Warrants [Member]	Dec. 31, 2012 Minimum [Member] Stock Options and Warrants [Member]	Dec. 31, 2011 Minimum [Member] Stock Options and Warrants [Member]	Sep. 30, 2013 Maximum [Member]	Dec. 31, 2013 Maximum [Member]	Dec. 31, 2008 Maximum [Member]	Sep. 10, 2013 Maximum [Member]	Dec. 31, 2013 Maximum [Member] Warrant [Member]	Dec. 31, 2013 Maximum [Member] Stock Options and Warrants [Member]	Dec. 31, 2012 Maximum [Member] Stock Options and Warrants [Member]	Dec. 31, 2011 Maximum [Member] Stock Options and Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Remaining Life																		6 months		2 years 6 months																																				5 years	3 years		10 years	5 years		10 years			2 years 6 months					3 years			7 years 6 months					10 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum																		0.13%			2.00%																																					0.34%
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum																		2.97%			4.50%																																					2.44%
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate																		0.00%			0.00%																																			0.00%	0.00%	0.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum																					53.00%																																					54.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum																					66.00%																																					66.00%
Issued - Average Exercise Price																																$ 0.12	[1]	$ 0.15	[1]	$ 0.14	[1]	$ 0.34	[1]	$ 0.65	[1]	$ 0.45	[1]	$ 0.35	[1]	$ 0.85	[1]																	$ 0.119	$ 0.102		$ 0.01		$ 0.0111	$ 0.0126		$ 0.242	$ 0.336		$ 0.769		$ 0.096	$ 0.3412
Convertible Debt, Issuance Of Warrants													$ 100,000
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Volatility Description																		The Company compiled historical volatilities over a period of 2 to 7 years of 15 small-cap medical companies traded on major exchanges and 10 mid-range medical companies on the OTC Bulletin Board and combined the results using a weighted average approach.
Amortization of debt discount						33,469	47,908	7,232	15,553	96,613	30,150	92,700	40,242				275,640	413,695	57,518			756,497
Debt Instrument Convertible Remaining Discount Amortization Period 1							24 months	24 months	18 months	22 months	24 months		5 years
Convertible Bridge Debt, Issuance Of Warrants												170,000
Debt Instrument, Maturity Date												Apr. 30, 2008
Proceeds from Issuance of Debt							50,000	16,800	32,000	200,000	100,000																																									27,500	27,500	51,243	50,000
Warrants Issued During Period, Shares, In Connection With Convertible Debt							1,595,239	200,000	320,000	1,111,112	200,000
Equity Issuance Per Share Amount						$ 0.10	$ 0.20	$ 0.084	$ 0.18	$ 0.46	$ 0.65											$ 1.67
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate																				1.37%																																																0.78%	0.33%							2.04%	1.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate																		54.00%		63.00%																																					54.00%		59.00%	59.00%	66.00%	66.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number																		27,658,652				27,658,652
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price																		$ 0.085				$ 0.085
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term 1																		8 years 9 months 18 days
Share-based Compensation Expense																		3,700,070	830,372
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Stock Options																		166,905				166,905
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1																		22 months
Stockholders' Equity, Reverse Stock Split																					Under theterms of the Company's agreement with investors in the October 2008 financing, 1,920,000 shares of common stock were the maximum number of shares allocated to the Company's existing shareholders at the time of the offering (also referred to as the original shareholders or the "Founders"). Since the total of the Company's fully diluted shares of common stock was greater than 1,920,000 shares, in order for the Company to proceed with the offering, the Board of Directors approved a reverse stock split of 1-for-1.2545. After this split was approved, additional options and warrants were identified, requiring a second reverse stock split in order to reach the 1,920,000 shares. The second reverse stock split on the reduced 1-for-1.2545 balance was determined to be 1-for-1.33176963. Taken together, if only one reverse stock split was performed, the number would have been a reverse stock split of 1-for-1.670705. On June 6, 2008, the Board of Directors approved the first reverse stock split. The authorized number of shares of common stock of 20,000,000 was proportionately divided by 1.2545 to arrive at 15,942,607. On October 20, 2008, the Board of Directors (i) approved the second reverse stock split pursuant to which the authorized number of shares of common stock of 15,942,607 was proportionately divided by 1.33177 to arrive at 11,970,994 shares and (ii) approved a resolution to increase the number of authorized shares of the Company's common stock from 11,970,994 to 40,000,000, which was approved by the Companys shareholders holding a majority of the shares entitled to vote thereon at a special meeting of shareholders held on December 3, 2008.
Common stock, shares authorized																		800,000,000	800,000,000			800,000,000		300,000,000		200,000,000	80,000,000																							100,000,000	50,000,000															300,000,000								800,000,000
Convertible Note Conversion Price					$ 0.12																								$ 0.18
Debt Instrument, Face Amount						156,243																						300,000		1,000,000	1,000,000
Convertible Notes Converted Into Common Stock			1,116,084		2,500,000																							2,500,000		6,000,000	4,611,111
Debt Instrument, Convertible, Conversion Price				$ 0.10	$ 0.12																		$ 0.014		$ 0.065			$ 0.15
Accumulated discounts on current portion of convertible debt (in dollars)					77,644													0	21,138			0
Debt Instrument, Convertible, Effective Interest Rate																		24.00%				24.00%						8.00%		8.00%	8.00%
Shares Grants Increase For Threshold																																																			20,000,000
Shares issued under PPM to five investors at $.07 per share (in shares)	7,142,858															7,142,857																																7,142,858	7,142,857
Shares issued under PPM to five investors	$ 0.07															$ 0.07		$ 0.07
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01															$ 0.01	$ 0.01			$ 0.01
Warrants Exercise Price	$ 0.08	$ 0.25	$ 0.10											$ 0.10	$ 0.18																$ 0.198																	$ 0.15	$ 0.15														$ 0.15								$ 0.46
Shares issued under PPM to five investors at $.07 per share																		500,000																														500,000	500,000
Warrants Issued To Purchase Common Stock																	444,444
Debt Instrument Interest						11,169
Stock Issued During Period, Shares, New Issues			357,163	1,041,622
CommonStocksharesIssuedToConsultantExercisingOptions				200,000	200,000
Common stock issued to former CEO exercising option, par value				$ 0.01														$ 0.01
Common stock issued to former consultant exercising option, Par value				$ 0.01														$ 0.01
Common stock shares issued to CEO exercising options.				333,330
Stock Issued During Period, Value, Issued To Twenty Four Warrant Holders														1,044,490				1,044,490
Stock Issued During Period, Shares, Issued To Twenty Four Warrant Holders														10,444,898
Issuance of net exercise provision shares														6,533,788
Share Based Compensation Arrangement By Share Based Payment Award Warrant Vested And Expected To Vest Exercisable Number																		34,643,829				34,643,829
Shares Issued To One Warrant Holder Exercised At Reduced Par Value		$ 0.125																$ 0.125
Stock Issued During Period Value Issued To One Warrant Holders		$ 125,000																$ 125,000
Stock Issued During Period Shares Issued To One Warrant Holders		1,000,000

[1] Adjusted for the reverse stock splits in total at June 6, 2008 and October 20, 2008.